VRCA · Verrica Pharmaceuticals Inc.

Summary

Verrica Pharmaceuticals Inc. filed an 8-K on March 11, 2026, disclosing results of operations under Item 2.02, with Exhibit 99.1 Press Release attached. The information under Item 2.02 and Exhibit 99.1 is not deemed 'filed' for purposes of Section 18 of the Exchange Act.

Key takeaways

• Form 8-K filed on 2026-03-11
• Item 2.02 Results of Operations disclosed
• Exhibit 99.1 Press Release dated 2026-03-11
• Item 9.01 Financial Statements and Exhibits
• Exhibit 104 Cover Page Interactive Data File
• Item 2.02 and Exhibit 99.1 not deemed 'filed' under Section 18 of Exchange Act